BlackRock Investment Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

BlackRock Investment Management’s Portfolio AMPE Stock Details AMPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$147K	Hold	544	–	–	﹤0.01%	3250
2016 Q3	$121K	Hold	544	–	–	﹤0.01%	3267
2016 Q2	$211K	Buy	544 +519	+2,076%	+$567K	﹤0.01%	3269
2016 Q1	$17K	Hold	25	–	–	﹤0.01%	3429
2015 Q4	$27K	Hold	25	–	–	﹤0.01%	3363
2015 Q3	$21K	Hold	25	–	–	﹤0.01%	3430
2015 Q2	$17K	Sell	25 -377	-94%	-$402K	﹤0.01%	3509
2015 Q1	$908K	Sell	402 -6	-1%	-$10.2K	﹤0.01%	2591
2014 Q4	$420K	Buy	408 +1	+0.2%	+$1.07K	﹤0.01%	3085
2014 Q3	$431K	Buy	407 +12	+3%	+$20.2K	﹤0.01%	3047
2014 Q2	$989K	Buy	395 +45	+13%	+$91.8K	﹤0.01%	2612
2014 Q1	$668K	Buy	350 +64	+22%	+$151K	﹤0.01%	2797
2013 Q4	$612K	Buy	286 +23	+9%	+$54.4K	﹤0.01%	2852
2013 Q3	$593K	Buy	263 +21	+9%	+$40.6K	﹤0.01%	2815
2013 Q2	$419K	Buy	+242	New	+$384K	﹤0.01%	2948

Other funds holding AMPE

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NFG

Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

BlackRock Investment Management's AMPE Position: Q4 2016 in Review

BlackRock Investment Management held its Ampio Pharmaceuticals Inc. (AMPE) position steady in Q4 2016 at 544 shares worth $147K. The position accounts for ﹤0.01% of the portfolio, ranked #3250.

BlackRock Investment Management first reported a position in AMPE in Q2 2013 and has held it in 15 quarters since. The position peaked at $989K in Q2 2014. 71 funds tracked by Wall St. Rank hold AMPE as of Q4 2016.

BlackRock Investment Management held 544 shares of Ampio Pharmaceuticals Inc. worth $147K as of Q4 2016.
BlackRock Investment Management left its Ampio Pharmaceuticals Inc. share count unchanged in Q4 2016.
Ampio Pharmaceuticals Inc. made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3250 holding.
BlackRock Investment Management first reported a position in Ampio Pharmaceuticals Inc. in Q2 2013 and has held it in 15 quarters since.
BlackRock Investment Management's Ampio Pharmaceuticals Inc. position peaked at $989K in Q2 2014.
71 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.